Aliases & Classifications for Social Phobia

About this section

Aliases & Descriptions for Social Phobia:

Name: Social Phobia 10 12
Phobic Anxiety Disorder 65
Phobic Disorders 36
 
Phobia, Social 65
Phobia Social 47

Classifications:



External Ids:

Disease Ontology10 DOID:11257
ICD9CM29 300.23
MeSH36 D010698
NCIt42 C34927
UMLS65 C0031572

Summaries for Social Phobia

About this section
Disease Ontology:10 A phobic disorder that involves social anxiety occurring only in specific public or social situations, interactions with others or being evaluated or scrutinized by other people.

MalaCards based summary: Social Phobia, also known as phobic anxiety disorder, is related to dependent personality disorder and drug dependence, and has symptoms including unreasonable fear of seeing an injury, unreasonable fear of injury related events and death anxiety. An important gene associated with Social Phobia is MAOA (Monoamine Oxidase A), and among its related pathways are Monoamine Transport and Dopamine metabolism. The drugs gabapentin enacarbil and gabapentin have been mentioned in the context of this disorder. Affiliated tissues include brain, t cells and thyroid, and related mouse phenotypes are tumorigenesis and endocrine/exocrine gland.

Related Diseases for Social Phobia

About this section

Diseases related to Social Phobia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 109)
idRelated DiseaseScoreTop Affiliating Genes
1dependent personality disorder30.3MAOA, SLC6A4
2drug dependence29.8DRD2, MAOA, SLC6A4
3schizophrenia28.7DRD2, HTR3A, MAOA, PRL, SLC6A4
4phobic disorder12.2
5personality disorder10.6
6avoidant personality disorder10.6
7anxiety disorder10.6
8panic disorder10.6
9hairy cell leukemia10.5MAOA, PRL
10agoraphobia10.5
11vogt-koyanagi-harada disease10.5MAOA, SLC6A4
12tympanosclerosis10.4MAOA, SLC6A4
13brachial plexus neoplasm10.4MAOA, SLC6A4
14generalized anxiety disorder10.4
15perrault syndrome10.4MAOA, SLC6A4
16deafness and myopia10.4MAOA, PRL
17intermittent explosive disorder10.4MAOA, SLC6A4
18ovarian mixed germ cell neoplasm10.4MAOA, SLC6A4
19paraphilia disorder10.4PRL, SLC6A4
20lymphadenitis10.3MAOA, SLC6A4
21obsessive-compulsive disorder10.3
22peripheral resistance to thyroid hormones10.3DRD2, PRL
23kleptomania10.3DRD2, MAOA
24ainhum10.3DRD2, PRL
25mutism10.3
26lipoadenoma10.3DRD2, PRL
27hallucinogen dependence10.3DRD2, MAOA
28prolactin producing pituitary tumor10.2DRD2, PRL
29cold-induced sweating syndrome 210.2DRD2, PRL
30kluver-bucy syndrome10.2DRD2, SLC6A4
31prostate adenocarcinoma10.2DRD2, SLC6A4
32geniculate herpes zoster10.2DRD2, SLC6A4
33trichinosis10.2HTR3A, SLC6A4
34amusia10.2DRD2, SLC6A4
35blepharochalasis10.1CAT, PRL
36alpha-methylacyl-coa racemase deficiency10.1DRD2, PRL
37tabes dorsalis10.1DRD2, SLC6A4
38heroin dependence10.1DRD2, SLC6A4
39ulcerative blepharitis10.1MAOA, PRL, SLC6A4
40atypical depressive disorder10.1MAOA, PRL, SLC6A4
41factor viii deficiency10.1HTR3A, SLC6A4
42body dysmorphic disorder10.1
43separation anxiety disorder10.1
44strabismus10.1
45laryngeal adductor paralysis10.1MAOA, PRL, SLC6A4
46melancholia10.1DRD2, SLC6A4
47vascular erectile tumor10.1HTR3A, SLC6A4
48viral exanthem10.0DRD2, SLC6A4
49cocaine dependence10.0DRD2, SLC6A4
50bone diseases10.0PRL, SOD1

Comorbidity relations with Social Phobia via Phenotypic Disease Network (PDN):


Dysthymic DisorderAnxiety Disorder

Graphical network of the top 20 diseases related to Social Phobia:



Diseases related to social phobia

Symptoms for Social Phobia

About this section

UMLS symptoms related to Social Phobia:


unreasonable fear of seeing an injury, unreasonable fear of injury related events, death anxiety, child behavior symptom/complaint

Drugs & Therapeutics for Social Phobia

About this section

Drugs for Social Phobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 185)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Acamprosateapproved, investigationalPhase 43877337-76-971158
Synonyms:
3-(Acetylamino)propanesulphonic acid
3-Acetamido-1-propanesulfonic acid
3-acetamidopropane-1-sulfonic acid
77337-70-3 (mono-hydrochloride salt)
77337-71-4 (mono-potassium salt)
77337-72-5 (mono-lithium salt)
77337-73-6 (calcium[2:1] salt)
77337-74-7 (magnesium[2:1] salt)
77337-76-9
AC1L2FNA
AC1Q1L6O
AC1Q6X8K
AOTA
AR-1H6082
Acamprosate
Acamprosate (INN)
Acamprosate 6473
Acamprosate Calcium
Acamprosate [INN:BAN]
Acamprosato
Acamprosato [INN-Spanish]
 
Acamprosatum
Acamprosatum [INN-Latin]
Aotal
Aotal (TN)
C5H11NO4S
CHEBI:51041
CID71158
Campral
D07058
DB00659
EINECS 278-667-4
HSDB 7358
LS-120940
N-Acetylhomotaurine
N-acetyl homotaurine
UNII-N4K14YGM3J
acamprosate
acamprosate (Campral)
acamprostate
calcium acetyl homotaurinate
calcium acetylhomotaurinate
calcium acetylhomotaurine
sodium acetylhomotaurine
2
Clonazepamapproved, illicitPhase 4261622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
 
DEA No. 2737
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
3
Aripiprazoleapproved, investigationalPhase 4342129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify DISCMELT
Abilify Discmelt
Abilify Maintena
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
 
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
4
Paroxetineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 122161869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
Brisdelle
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine Hydrochloride
Paroxetine Mesylate
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
5
NorepinephrineapprovedPhase 4, Phase 359551-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
 
LT03330026
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
6
DopamineapprovedPhase 4, Phase 3, Phase 2308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
7
SertralineapprovedPhase 4, Phase 3, Phase 228279617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
8
LidocaineapprovedPhase 41103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
9
TiagabineapprovedPhase 420115103-54-360648
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
115103-54-3
A-70569-1
ABBOTT-70569-1
AC-7048
AC1L1TNE
AC1Q5R43
BIDD:GT0018
C07503
C20H25NO2S2
CHEBI:222170
CHEMBL1027
CID60648
D08588
DB00906
 
Gabitril
Gabitril (TN)
HSDB 7527
LS-114651
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NCGC00164626-01
NO 329
NO-328
NO-329
Tiagabina
Tiagabina [INN-Spanish]
Tiagabine (INN)
Tiagabine [INN:BAN]
Tiagabine [INN]
Tiagabinum
Tiagabinum [INN-Latin]
UNII-Z80I64HMNP
tiagabine
10
CitalopramapprovedPhase 4, Phase 2, Phase 3, Phase 149459729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Perrigo Citalopram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
11
CycloserineapprovedPhase 4, Phase 3, Phase 2, Phase 1, Phase 010368-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
12
TopiramateapprovedPhase 424097240-79-45284627
Synonyms:
-D-fructopyranose deriv.
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
CPD000466325
Cilag brand of topiramate
D00537
DB00273
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
MLS000759431
MLS001424070
McN 4853
McN-4853
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
Ortho brand of topiramate
 
Qudexy XR
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
STOCK1N-71037
Spectrum2_001128
T0575_SIGMA
TL8006021
TOR
TPM
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Topamac
Topamax
Topamax (TN)
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
Trokendi Xr
UNII-0H73WJJ391
USL-255
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
topiramate
topiramate tablet
topiramatum [Latin]
13Anti-Anxiety AgentsPhase 4, Phase 3, Phase 2, Phase 11529
14Antiparkinson AgentsPhase 4, Phase 2, Phase 3, Phase 11312
15Protective AgentsPhase 4, Phase 25651
16Neuroprotective AgentsPhase 4, Phase 21376
17Nootropic AgentsPhase 4, Phase 2604
18PiracetamPhase 4, Phase 21367491-74-9
19Cholinergic AgentsPhase 4, Phase 2, Phase 3, Phase 13243
20Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 018510
21Dopamine Uptake InhibitorsPhase 4925
22Dopamine AgentsPhase 4, Phase 3, Phase 23084
23Serotonin AntagonistsPhase 4, Phase 21175
24AnalgesicsPhase 4, Phase 3, Phase 09358
25Antipsychotic AgentsPhase 4, Phase 3, Phase 2, Phase 02130
26Phase 4, Phase 2
27Atomoxetine HydrochloridePhase 4, Phase 2, Phase 3160
28Muscarinic AntagonistsPhase 4, Phase 2, Phase 3, Phase 1961
29ParasympatholyticsPhase 4, Phase 2, Phase 3, Phase 1902
30EtiracetamPhase 4, Phase 2196
31Adrenergic AgentsPhase 4, Phase 2, Phase 34204
32Cholinergic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11423
33Central Nervous System StimulantsPhase 41721
34Cytochrome P-450 CYP2D6 InhibitorsPhase 4, Phase 3, Phase 2, Phase 1602
35Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 1, Phase 010016
36Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 2, Phase 13036
37Neurotransmitter AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 014795
38Neurotransmitter Uptake InhibitorsPhase 4, Phase 2, Phase 3, Phase 12857
39Contraceptives, OralPhase 4, Phase 3, Phase 2, Phase 1, Phase 03734
40Antidepressive Agents, Second-GenerationPhase 4, Phase 2, Phase 3, Phase 11087
41Psychotropic DrugsPhase 4, Phase 2, Phase 3, Phase 1, Phase 05501
42Tranquilizing AgentsPhase 4, Phase 3, Phase 2, Phase 1, Phase 03597
43GABA AgonistsPhase 4120
44Antidepressive AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 02367
45Quetiapine FumaratePhase 4, Phase 3, Phase 2, Phase 0403111974-72-2
46
SerotoninPhase 4, Phase 2, Phase 3, Phase 1314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
47GABA ModulatorsPhase 4, Phase 1657
48AnticonvulsantsPhase 4, Phase 22249
49Serotonin and Noradrenaline Reuptake InhibitorsPhase 4, Phase 3391
50Venlafaxine HydrochloridePhase 4, Phase 3185

Interventional clinical trials:

(show top 50)    (show all 283)
idNameStatusNCT IDPhase
1The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking EnvironmentCompletedNCT00407199Phase 4
2RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and PlaceboCompletedNCT00184106Phase 4
3D-Cycloserine Enhancement of Exposure in Social PhobiaCompletedNCT00633984Phase 4
4Nefazodone in the Treatment of Social PhobiaCompletedNCT00231348Phase 4
5Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety DisorderCompletedNCT00282828Phase 4
6Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588Phase 4
7Paroxetine for Comorbid Social Anxiety Disorder and AlcoholismCompletedNCT00246441Phase 4
8Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety DisorderCompletedNCT00872131Phase 4
912-Week Study of Pristiq (Desvenlafaxine) Social Anxiety DisorderCompletedNCT01316302Phase 4
10Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety DisorderCompletedNCT00208741Phase 4
11Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic DisorderCompletedNCT00265109Phase 4
12Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic DisorderCompletedNCT00767871Phase 4
13Primary Care Intervention Strategy for Anxiety DisordersCompletedNCT00347269Phase 4
14Escitalopram in Patients With Social Anxiety DisorderCompletedNCT00902226Phase 4
15Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCompletedNCT00190879Phase 4
16Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietyCompletedNCT00177008Phase 4
17Acamprosate in Alcoholics With Comorbid Anxiety or DepressionCompletedNCT00330174Phase 4
18Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersRecruitingNCT00182533Phase 4
19Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)RecruitingNCT00182455Phase 4
20Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder ComorbidityRecruitingNCT01863459Phase 4
21Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in AdultsActive, not recruitingNCT01224067Phase 4
22Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety DisorderNot yet recruitingNCT02294305Phase 4
23Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle PhobiasTerminatedNCT01623583Phase 4
24Study of Escitalopram in the Treatment of Specific PhobiaCompletedNCT00121069Phase 2, Phase 3
25Treatment of Childhood Social PhobiaCompletedNCT00043537Phase 3
26Residential Cognitive and Interpersonal Therapy for Social PhobiaCompletedNCT00326430Phase 2, Phase 3
27Treatment of Social Phobia and Panic Disorder in AdultsCompletedNCT00619138Phase 3
28Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social PhobiaCompletedNCT00515879Phase 3
29A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural TherapyCompletedNCT00564967Phase 3
30D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for AcrophobiaCompletedNCT01102803Phase 3
31Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic ParticipantsCompletedNCT00734422Phase 2, Phase 3
32Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic ParticipantsCompletedNCT02007694Phase 2, Phase 3
33Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social AnxietyCompletedNCT00958880Phase 3
34Social Anxiety Disorder Study Of ParoxetineCompletedNCT00318669Phase 3
35Long-term Study Of Paroxetine in Women and MenCompletedNCT00264654Phase 3
36St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)CompletedNCT00118833Phase 2, Phase 3
37Flushing in Social Anxiety Disorder on SeroquelCompletedNCT00773162Phase 3
38Quetiapine in Social Anxiety DisorderCompletedNCT00215254Phase 2, Phase 3
39Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health CentersCompletedNCT01416805Phase 3
40Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3
41Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety DisorderCompletedNCT00260533Phase 2, Phase 3
42Duloxetine for Social Anxiety Disorder: Prediction of Long Term OutcomeCompletedNCT00114127Phase 3
43Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)CompletedNCT02622958Phase 3
44Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety DisorderCompletedNCT00074802Phase 3
45Psychological Support for Patients With an Implantable Cardioverter DefibrillatorCompletedNCT00152763Phase 3
46Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
47Treatment of Panic Disorder: Long Term StrategiesCompletedNCT00000368Phase 3
48Virtual Reality Exposure Therapy in Agoraphobic ParticipantsCompletedNCT00734370Phase 2, Phase 3
49Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00088036Phase 3
50Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety DisorderCompletedNCT00238719Phase 3

Search NIH Clinical Center for Social Phobia

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: phobic disorders

Genetic Tests for Social Phobia

About this section

Anatomical Context for Social Phobia

About this section

MalaCards organs/tissues related to Social Phobia:

33
Brain, T cells, Thyroid, Prostate, Heart, Pituitary, Eye

Animal Models for Social Phobia or affiliated genes

About this section

MGI Mouse Phenotypes related to Social Phobia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.2CAT, DRD2, PRL, SOD1
2MP:00053797.9DRD2, HTR3A, PRL, SLC6A4, SOD1
3MP:00107717.8DRD2, HTR3A, PRL, SLC6A4, SOD1
4MP:00053867.3DRD2, HTR3A, MAOA, PRL, SLC6A4, SOD1
5MP:00036317.0DRD2, HTR3A, MAOA, PRL, SLC6A4, SOD1
6MP:00053766.7CAT, DRD2, HTR3A, MAOA, PRL, SLC6A4

Publications for Social Phobia

About this section

Articles related to Social Phobia:

(show top 50)    (show all 595)
idTitleAuthorsYear
1
Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia. (26288643)
2015
2
Behavioral treatment of social phobia in youth: Does parent education training improve the outcome? (25727679)
2015
3
The primary care diagnosis and management of social phobia and its relevance in the UK Armed Forces. (23691857)
2013
4
An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol. (23895258)
2013
5
The SPAI-18, a brief version of the Social Phobia and Anxiety Inventory: Reliability and validity in clinically referred and non-referred samples. (23790687)
2013
6
Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia. (20797795)
2011
7
Social phobia and other psychiatric problems in children with strabismus. (21784213)
2011
8
Social fear and social phobia types among community youth: differential clinical features and vulnerability factors. (20684833)
2011
9
A randomized pilot study of mindfulness-based cognitive therapy and group cognitive-behavioral therapy for young adults with social phobia. (20210911)
2010
10
Learning to change a way of being: an interpretative phenomenological perspective on cognitive therapy for social phobia. (20413253)
2010
11
Task-dependent neural correlates of the processing of verbal threat-related stimuli in social phobia. (20227458)
2010
12
Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review. (20055730)
2010
13
Social norm processing in adult social phobia: atypically increased ventromedial frontal cortex responsiveness to unintentional (embarrassing) transgressions. (20889651)
2010
14
Health anxiety and fear of fear in panic disorder and agoraphobia vs. social phobia: a prospective longitudinal study. (20143435)
2010
15
Social phobia in late-life: is it worth a diagnosis? (20597874)
2010
16
Randomized controlled trial of Internet cognitive behavioural treatment for social phobia with and without motivational enhancement strategies. (20932208)
2010
17
Further study of the psychometric qualities of a brief screening tool for social phobia (MINI-SPIN) applied to clinical and nonclinical samples. (20883433)
2010
18
Cognitive behavioral group therapy for social phobia with or without attention training: a controlled trial. (19059753)
2009
19
Dreams In Jungian Psychology: The use of Dreams as an Instrument For Research, Diagnosis and Treatment of Social Phobia. (22135511)
2009
20
Changes in post-event processing and metacognitions during cognitive behavioral group therapy for social phobia. (19250799)
2009
21
A demonstration of the efficacy of two of the components of cognitive therapy for social phobia. (19081225)
2009
22
Social phobia and avoidant personality disorder: are they separate diagnostic entities or do they reflect a spectrum of social anxiety? (19728570)
2009
23
Assessing post-event processing after social situations: a measure based on the cognitive model for social phobia. (18350392)
2008
24
Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease. (18661550)
2008
25
A new proposal for the subtypes of social phobia in a sample of Spanish adolescents. (17367987)
2008
26
Screening for social phobia in medical in- and outpatients with the German version of the Social Phobia Inventory (SPIN). (17923381)
2008
27
Shyness 2: treating social phobia online: replication and extension. (18612863)
2008
28
Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. (17974937)
2007
29
Group cohesion in cognitive-behavioral group therapy for social phobia. (16928359)
2007
30
Treatment of social phobia through pure self-help and therapist-augmented self-help. (17766766)
2007
31
The social phobia and anxiety inventory: problem of underlying medical conditions. (18232422)
2007
32
Specificity of autobiographical memory in social phobia and major depression. (17472199)
2007
33
Temperament and character dimensions in patients with social phobia: patterns of change following treatments? (17328961)
2007
34
Therapeutic factors of cognitive behavioral group treatment for social phobia. (16614524)
2006
35
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. (15930067)
2005
36
Intensive cognitive behavioural group treatment for social phobia: a pilot study. (15844687)
2005
37
Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia. (15860337)
2005
38
Comparing the prevalence rates of social phobia in a community according to ICD-10 and DSM-III-R. (16224610)
2005
39
Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobia. (16129496)
2005
40
Emerging treatments for child and adolescent social phobia: a review. (16190791)
2005
41
EEG mapping in patients with social phobia. (15465293)
2004
42
Social phobia and avoidant personality disorder: one spectrum disorder? (15204221)
2004
43
Social Phobia in an Italian region: do Italian studies show lower frequencies than community surveys conducted in other European countries? (15488146)
2004
44
Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. (14702251)
2004
45
Childhood stress and symptoms of drug dependence in adolescence and early adulthood: social phobia as a mediator. (9990437)
1999
46
The observer perspective: biased imagery in social phobia, agoraphobia, and blood/injury phobia. (10402690)
1999
47
Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. (9704868)
1998
48
Moclobemide in the treatment of social phobia. (8923114)
1996
49
Is elective mutism a social phobia? (8407760)
1993
50
Avoidant personality disorder and the generalized subtype of social phobia. (1583226)
1992

Variations for Social Phobia

About this section

Expression for genes affiliated with Social Phobia

About this section
Search GEO for disease gene expression data for Social Phobia.

Pathways for genes affiliated with Social Phobia

About this section

GO Terms for genes affiliated with Social Phobia

About this section

Biological processes related to Social Phobia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1response to inactivityGO:00148549.9CAT, DRD2
2cellular response to growth factor stimulusGO:00713639.6CAT, HTR3A
3response to axon injuryGO:00486789.5DRD2, SOD1
4response to estradiolGO:00323559.4CAT, SLC6A4
5response to ethanolGO:00454719.4DRD2, SOD1
6response to reactive oxygen speciesGO:00003029.3CAT, SOD1
7response to oxidative stressGO:00069799.2CAT, SOD1
8locomotory behaviorGO:00076269.1DRD2, SOD1
9response to amphetamineGO:00019758.8DRD2, SOD1
10response to drugGO:00424938.2CAT, DRD2, SLC6A4, SOD1

Sources for Social Phobia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet